Drugs / Recombinant HBsAg
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00697242 | Jan 1994 → Nov 1995 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant HBsAg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00697242 ↗ |
| Modality | Vaccine | “recombinant hepatitis B vaccines with and without MPL” NCT00697242 ↗ |
| Route | Intramuscular | “Intramuscular injection, 3 doses” NCT00697242 ↗ |